基于疗效/毒性整合和双方网络建模,为急性髓性白血病设计以患者为导向的组合疗法
Mehdi Mirzaie1, Elham Gholizadeh1, Juho J Miettinen2
1Department of Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland.
Oncogenesis
|March 1, 2024
概括
这项研究引入了一种计算网络方法,以发现急性髓性白血病 (AML) 的有效药物组合. 研究确定了ruxolitinib-ulixertinib和sapanisertib-LY3009120作为具有低毒性的有希望的协同治疗方法.
科学领域:
- 血液学 血液学 血液学
- 计算生物学 计算生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性髓性白血病 (AML) 是一种侵袭性癌症,通常需要联合药物治疗.
- 目前用于药物组合的计算方法主要集中在协同作用上,忽视了疗效和毒性.
- 个性化治疗策略对于改善AML患者的治疗结果至关重要.
研究的目的:
- 开发一种计算模型,用于识别AML的有效和低毒性药物组合.
- 使用双边网络方法探索药物反应异质性.
- 在临床前模型中验证新药组合.
主要方法:
- 建立了一个双边网络,整合了患者瘤样本和药物反应数据.
- 将网络投射到药物上,以创建一个药物相似性网络.
- 利用社区检测和途径分析来识别针对不同生物过程的药物集群.
- 从每个集群中选择高效,低毒性药物,通过细胞活力测试进行验证.
主要成果:
- 确定了不同的药物集群,针对AML的不同生物途径.
- 卢克索利提尼布-乌利克塞尔提尼布和萨帕尼塞尔提布-LY3009120对AML爆发细胞表现出显著的协同作用.
- 与单个药物相比,这些组合表现出优越的疗效与最小的毒性.
- 药物组合在临床前细胞活力试验中显示出有希望的结果.
结论:
- 开发的计算网络方法有效地识别了AML的协同药物组合.
- 卢克索利提尼布-乌利克塞尔提尼布和萨帕尼塞尔提布-LY3009120是新型AML组合疗法的有希望的候选人.
- 这些发现支持开发个性化的AML治疗策略.
- 鉴定的组合有可能补充标准的第一线AML治疗方法.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:12Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
01:28Structure-Activity Relationships and Drug Design
718
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
718